Matches in Wikidata for { <http://www.wikidata.org/entity/Q58571726> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q58571726 description "article" @default.
- Q58571726 description "im Jahr 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q58571726 description "wetenschappelijk artikel" @default.
- Q58571726 description "наукова стаття, опублікована у 2018" @default.
- Q58571726 description "հոդված" @default.
- Q58571726 name "Ilumya® (Tildrakizumab): A Newly Approved Interluekin-23 Antagonist for the Treatment of Plaque Psoriasis" @default.
- Q58571726 name "Ilumya®" @default.
- Q58571726 type Item @default.
- Q58571726 label "Ilumya® (Tildrakizumab): A Newly Approved Interluekin-23 Antagonist for the Treatment of Plaque Psoriasis" @default.
- Q58571726 label "Ilumya®" @default.
- Q58571726 prefLabel "Ilumya® (Tildrakizumab): A Newly Approved Interluekin-23 Antagonist for the Treatment of Plaque Psoriasis" @default.
- Q58571726 prefLabel "Ilumya®" @default.
- Q58571726 P1433 Q58571726-D99BA059-B710-45FE-A707-56730038EEA2 @default.
- Q58571726 P1476 Q58571726-F3E2AE39-1D98-42AD-BD67-02917F1F6CDB @default.
- Q58571726 P2093 Q58571726-2DFF1CDD-736A-4521-9543-8B33CB82DD4F @default.
- Q58571726 P2093 Q58571726-9E8E577D-A835-406B-A801-874A57D7419D @default.
- Q58571726 P2093 Q58571726-A76CCA7B-6D17-4851-9885-9FEF852B6D83 @default.
- Q58571726 P2093 Q58571726-DEF3D261-0F08-4A60-BA94-A959962D231D @default.
- Q58571726 P304 Q58571726-C6CFEF67-A9AF-4A44-8F04-2FA7249ECDB1 @default.
- Q58571726 P31 Q58571726-0071977D-3CD3-44C5-9671-4A1BD16CA303 @default.
- Q58571726 P407 Q58571726-C4138237-FA96-430E-AFE8-33BECEE7F1D4 @default.
- Q58571726 P433 Q58571726-E84D7904-B3B0-43F2-957A-F9A4B609BD46 @default.
- Q58571726 P478 Q58571726-9FBA3959-892B-4162-A3B0-7B59581EDABA @default.
- Q58571726 P577 Q58571726-DA843AA4-6C2A-43A4-9B4C-3EABB3286F62 @default.
- Q58571726 P698 Q58571726-2A998872-F6BA-47BB-9E5A-B8B8E8200F37 @default.
- Q58571726 P921 Q58571726-FB337BF5-869E-446C-8BD7-066A999BFD3C @default.
- Q58571726 P698 30413226 @default.
- Q58571726 P1433 Q27720724 @default.
- Q58571726 P1476 "Ilumya® (Tildrakizumab): A Newly Approved Interluekin-23 Antagonist for the Treatment of Plaque Psoriasis" @default.
- Q58571726 P2093 "Aditya K Gupta" @default.
- Q58571726 P2093 "Kimberly D Vincent" @default.
- Q58571726 P2093 "Sarah G Versteeg" @default.
- Q58571726 P2093 "William Abramovits" @default.
- Q58571726 P304 "321-324" @default.
- Q58571726 P31 Q13442814 @default.
- Q58571726 P407 Q1860 @default.
- Q58571726 P433 "5" @default.
- Q58571726 P478 "16" @default.
- Q58571726 P577 "2018-01-01T00:00:00Z" @default.
- Q58571726 P698 "30413226" @default.
- Q58571726 P921 Q10355321 @default.